跳至主要内容
临床试验/EUCTR2011-000397-59-BE
EUCTR2011-000397-59-BE进行中(未招募)不适用

Prevention of post-ERCP acute pancreatitis by heme-oxygenase activation through the administration of hemin: a prospective, randomized double blind controlled trial. - Hemin to prevent post-ERCP acute pancreatitis

未提供0 个研究点目标入组 294 人开始时间: 2011年2月23日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
294

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • one of the following:
  • - clinical criteria:
  • 1) past history of acute pancreatitis
  • 2) past history of post-ERCP acute pancreatitis
  • 3) normal serum bilirubin range
  • - technical criteria:
  • 1) injection of the main pancreatic duct
  • 2) biliary sphincteroplasty
  • 3) papillotomy (precut)
  • 4) pancreatic sphincterotomy
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • placement of a prophylactic pancreatic stent:
  • -sphincter of Oddi dysfunction
  • -ampullectomy
  • ongoing acute pancreatitis
  • known chronic pancreatitis (>grade 2 following cremer classification)
  • youger than 18 y/o
  • allergy to hemin
  • renal failure (creatininemia>2mg/dl)

研究者

发起方
未提供

相似试验

Prevention of post-ERCP acute pancreatitis by... | 临床试验